Oitabén, A.; Fonseca, P.; Villanueva, M.J.; GarcÃa-Benito, C.; López-López, A.; Garrido-Fernández, A.; González-Ojea, C.; Juaneda-Magdalena, L.; Lázaro, M.E.; MartÃnez-Fernández, M.
Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC. Cancers 2022, 14, 2626.
https://doi.org/10.3390/cancers14112626
AMA Style
Oitabén A, Fonseca P, Villanueva MJ, GarcÃa-Benito C, López-López A, Garrido-Fernández A, González-Ojea C, Juaneda-Magdalena L, Lázaro ME, MartÃnez-Fernández M.
Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC. Cancers. 2022; 14(11):2626.
https://doi.org/10.3390/cancers14112626
Chicago/Turabian Style
Oitabén, Ana, Pablo Fonseca, MarÃa J. Villanueva, Carme GarcÃa-Benito, Aida López-López, Alberto Garrido-Fernández, Clara González-Ojea, Laura Juaneda-Magdalena, MartÃn E. Lázaro, and Mónica MartÃnez-Fernández.
2022. "Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC" Cancers 14, no. 11: 2626.
https://doi.org/10.3390/cancers14112626
APA Style
Oitabén, A., Fonseca, P., Villanueva, M. J., GarcÃa-Benito, C., López-López, A., Garrido-Fernández, A., González-Ojea, C., Juaneda-Magdalena, L., Lázaro, M. E., & MartÃnez-Fernández, M.
(2022). Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC. Cancers, 14(11), 2626.
https://doi.org/10.3390/cancers14112626
